The therapeutic potential of a protective APOE allele for delaying AD was corroborated with a case of an individual carrying the presenilin-1 mutation, known to cause early onset AD with high disease penetrance, who was also homozygous for a protective APOE-ɛ3-Christchurch R136S mutation [36]. This evidence concerns the gene PSEN1 and Alzheimer disease.